Arteriovenous Malformation Market: Research Applications and Future Potential
The Arteriovenous Malformation Market is increasingly used in research for vascular anomalies, cerebral circulation, and minimally invasive therapies. Academic institutions and clinical labs use AVM studies to improve treatment protocols and patient safety.
Emerging technologies in embolic agents, radiosurgery devices, and robotic interventions expand the market’s potential by enabling safer, faster, and more efficient treatment options.
Market Outlook: Estimated at USD 1.1 billion in 2024, the market is projected to reach USD 2.4 billion by 2034, growing at a 7.0% CAGR.
1 visualização